InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Grey Michael G, 董事. Officer active across 3 companies, notably Horizon Therapeutics Public Ltd Co. Aggregated, 14 disclosures have been recorded. Activity tracked since 22 July 2021. The latest transaction was disclosed on 19 December 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Grey Michael G
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
50,000 股@ US$2.93627.3% 占其流量Common StockSEC:0001240122-25-000011:0
50,000 股@ US$2.93638.0% 占其流量Common StockSEC:0001240122-25-000007:0
50,000 股@ US$2.93661.5% 占其流量Common StockSEC:0001240122-25-000006:0
102,788 股0Common StockSEC:0001415889-24-024195:0
39,361 股@ US$116.5093.1% 占其流量Ordinary SharesSEC:0001209191-23-052373:0
20,000 股@ US$15.966.5% 占其流量Ordinary SharesSEC:0001209191-23-050737:0
392 股@ US$2.9361.3% 占其流量Common StockSEC:0001209191-23-049511:0
50,000 股0Common StockSEC:0001209191-23-043558:0
14,608 股@ US$2.93650.0% 占其流量Common StockSEC:0001209191-23-035831:0
14,608 股@ US$2.93648.7% 占其流量Common StockSEC:0001209191-23-027549:0
3,913 股Ordinary SharesSEC:0001209191-23-026748:0
50,000 股@ US$1.97100.0% 占其流量Common StockSEC:0001209191-22-048532:0
4,223 股Ordinary SharesSEC:0001209191-22-026465:0
5,000 股@ US$2.370.2% 占其流量Ordinary SharesSEC:0001209191-21-047977:0
14 条申报中的 14 条
About Grey Michael G
GREY MICHAEL G is Administrateur. He has 14 filings in total. In the recent filings available, which cover the period from 2021-07-23 to 2025-12-23, there were 0 EUR of purchases and 4347887 EUR of sales, with Levée d'options as the most common transaction type. He is listed as Director at Mirum Pharmaceuticals, Inc. and Horizon Therapeutics Public Ltd Co, and as Executive Chairman at Reneo Pharmaceuticals, Inc.
